Bioprocessing Applications

Bioprocessing plays a critical role in therapeutic development by supporting the efficient production, purification, and formulation of biologics such as monoclonal antibodies, cell and gene therapies, and vaccines. It helps maintain product quality, consistency, and scalability from early research through commercial manufacturing, bringing effective therapies to patients faster.

Our bioprocessing solutions support workflows from early process development through commercial manufacturing. Solutions include upstream systems for cell culture and expansion, downstream purification, and analytical tools for product safety, potency, and quality control. Each solution is designed to improve productivity, consistency, and speed across modalities, such as ADCs, cell and gene therapies, mAbs, mRNA, and vaccines.

Bioprocessing in early preclinical development focuses on flexibility, speed, and scalability to rapidly evaluate candidates and optimize small-scale processes. In contrast, commercial manufacturing emphasizes consistency, compliance, and efficiency at a large scale to allow reliable, high-yield production that meets regulatory standards. Bridging the gap between these stages requires scalable, connected solutions that support easy process transfer and reduce risk during scale-up.

Scaling introduces challenges such as maintaining yield and quality across volumes, securing the supply of raw materials, and aligning with CGMP and regulatory standards. Addressing these factors early supports consistent performance and helps minimize risk during scale-up.

We collaborate with organizations across biotech, biopharma, and CDMOs to align bioprocessing solutions with project goals. Our global network offers technical experience and regulatory insights to help advance programs from early development to large-scale manufacturing. By connecting products, services, and scientific support, we help reduce risk and accelerate progress toward clinical and commercial milestones.